| NDC Code | 42367-521-25 |
|---|
| Package Description | 1 VIAL, MULTI-DOSE in 1 CARTON (42367-521-25) / 4 mL in 1 VIAL, MULTI-DOSE |
|---|
| Product NDC | 42367-521 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Belrapzo |
|---|
| Non-Proprietary Name | Bendamustine Hydrochloride |
|---|
| Dosage Form | INJECTION |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20190603 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | NDA205580 |
|---|
| Manufacturer | Eagle Pharmaceuticals, Inc |
|---|
| Substance Name | BENDAMUSTINE HYDROCHLORIDE |
|---|
| Strength | 100 |
|---|
| Strength Unit | mg/4mL |
|---|
| Pharmacy Classes | Alkylating Activity [MoA], Alkylating Drug [EPC] |
|---|